Characterization of U.S. State Laws Requiring Health Care Provider Reporting of Perinatal Substance Use

Women's Health Issues

Volumn 27, Issue 3, 2017, Pages 264-270

  Jarlenski, Marian ^a   Hogan, Caroline ^b   Bogen, Debra L ^b,c   Chang, Judy C ^b,c   Bodnar, Lisa M ^a,b,c   Van Nostrand, Elizabeth ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIRTH; DRUG DEPENDENCE; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HUMAN; INTERRATER RELIABILITY; LAW; PERINATAL DRUG EXPOSURE; PERINATAL PERIOD; PREGNANT WOMAN; SUBSTANCE USE; UNITED STATES; ADULT; FEMALE; GOVERNMENT; INFANT; LEGISLATION AND JURISPRUDENCE; PREGNANCY; PSYCHOLOGY; PUBLIC HEALTH SERVICE; SUBSTANCE ABUSE;

ADULT; FEMALE; HEALTH PERSONNEL; HEALTH POLICY; HUMANS; INFANT; LEGISLATION AS TOPIC; PREGNANCY; PREGNANT WOMEN; PUBLIC HEALTH ADMINISTRATION; STATE GOVERNMENT; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 85010443307     PISSN: 10493867     EISSN: 18784321     Source Type: Journal    
DOI: 10.1016/j.whi.2016.12.008     Document Type: Article

References (29)

1. Administration for Children and Families. Parental Drug Use as Child Abuse. Available: www.childwelfare.gov/topics/systemwide/laws-policies/statutes/drugexposed/, 2016 Accessed: January 16, 2017.
2. American College of Obstetricians and Gynecologists Committee on Ethics. Committee opinion no. 633: Alcohol abuse and other substance use disorders: Ethical issues in obstetric and gynecologic practice. Obstetrics & Gynecology 125:6 (2015), 1529–1537.
3. Angelotta, C., Weiss, C.J., Angelotta, J.W., Friedman, R.A., A moral or medical problem? The relationship between legal penalties and treatment practices for opioid use disorders in pregnant women. Womens Health Issues 26:6 (2016), 595–601.
4. Barry, C.L., Huskamp, H.A., Goldman, H.H., A political history of federal mental health and addiction insurance parity. Milbank Quarterly 88:3 (2010), 404–433.
5. Behnke, M., Smith, V.C., Committee on Substance Abuse, & Committee on Fetus and Newborn. Prenatal substance abuse: Short- and long-term effects on the exposed fetus. Pediatrics 131:3 (2013), e1009–1024.
6. Byrt, T., Bishop, J., Carlin, J.B., Bias, prevalence and kappa. Journal of Clinical Epidemiology 46:5 (1993), 423–429.
7. Centers for Disease Control and Prevention. Vital signs: Overdoses of prescription opioid pain relievers and other drugs among women–United States, 1999–2010. MMWR Morbidity and Mortality Weekly Reports 62:26 (2013), 537–542.
8. Chang, J.C., Holland, C.L., Tarr, J.A., Rubio, D., Rodriguez, K.L., Kraemer, K.L.,. Arnold, R.M., Perinatal illicit drug and marijuana use: An observational study examining prevalence, screening, and disclosure. American Journal of Health Promotion, 2015, 10.4278/ajhp.141215-QUAL-625 Accessed: January 17, 2017.
9. Guttmacher Institute. Substance abuse during pregnancy. 2017, Author, New York Available: www.guttmacher.org/statecenter/spibs/spib_SADP.pdf Accessed: January 17, 2017.
10. Hsieh, H.F., Shannon, S.E., Three approaches to qualitative content analysis. Qualitative Health Research 15:9 (2005), 1277–1288.
11. Krans, E.E., Patrick, S.W., Opioid use disorder in pregnancy: Health policy and practice in the midst of an epidemic. Obstetrics & Gynecology 128:1 (2016), 4–10.
12. Lester, B.M., Andreozzi, L., Appiah, L., Substance use during pregnancy: Time for policy to catch up with research. Harm Reduction Journal, 1(1), 2004, 5.
13. MacMahon, J.R., Perinatal substance abuse: The impact of reporting infants to child protective services. Pediatrics, 100(5), 1997, E1.
14. Martin, J.A., Hamilton, B.E., Osterman, M.J.K., Curtin, S.C., Matthews, T.J., Births: Final data for 2013. National Vital Statistics Report 64:1 (2015), 1–65.
15. McCann, K.J., Twomey, J.E., Caldwell, D., Soave, R., Fontaine, L.A., Lester, B.M., Services used by perinatal substance-users with child welfare involvement: A descriptive study. Harm Reduction Journal, 7, 2010, 19.
16. Osterling, K.L., D'Andrade, A., Austin, M.J., Understanding and addressing racial/ethnic disproportionality in the front end of the child welfare system. Journal of Evidence-Based Social Work 5:1-2 (2008), 9–30.
17. Patrick, S.W., Schumacher, R.E., Benneyworth, B.D., Krans, E.E., McAllister, J.M., Davis, M.M., Neonatal abstinence syndrome and associated health care expenditures: United States, 2000–2009. JAMA 307:18 (2012), 1934–1940.
18. Roberts, S.C., Nuru-Jeter, A., Women's perspectives on screening for alcohol and drug use in prenatal care. Womens Health Issues 20:3 (2010), 193–200.
19. Roberts, S.C., Nuru-Jeter, A., Universal screening for alcohol and drug use and racial disparities in child protective services reporting. Journal of Behavioral Health Services Research 39:1 (2012), 3–16.
20. Roberts, S.C., Pies, C., Complex calculations: How drug use during pregnancy becomes a barrier to prenatal care. Maternal and Child Health Journal 15:3 (2011), 333–341.
21. Roberts, S.C., Zahnd, E., Sufrin, C., Armstrong, M.A., Does adopting a prenatal substance use protocol reduce racial disparities in CPS reporting related to maternal drug use? A California case study. Journal of Perinatology 35:2 (2015), 146–150.
22. Smith, L.M., LaGasse, L.L., Derauf, C., Grant, P., Shah, R., Arria, A.,. Lester, B.M., The infant development, environment, and lifestyle study: Effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth. Pediatrics 118:3 (2006), 1149–1156.
23. Substance Abuse and Mental Health Services Administration. Results from the 2013 National Survey on Drug Use and Health: Summary of national findings. 2014, Author, Rockville, MD.
24. Substance Abuse and Mental Health Services Administration. A collaborative approach to the treatment of pregnant women with opioid use disorders: Practice and policy considerations for child welfare, collaborating medical, and service providers. Available: https://ncsacw.samhsa.gov/files/Collaborative_Approach_508.pdf, 2016 Accessed: January 17, 2017.
25. Terplan, M., Longinaker, N., Appel, L., Women-centered drug treatment services and need in the United States, 2002-2009. American Journal of Public Health 105:11 (2015), e50–54.
26. U.S. House of Representatives Committee on Education and the Workforce. Committee conducts oversight of child abuse prevention policies. Available: http://edworkforce.house.gov/news/documentsingle.aspx?DocumentID=400097, 2016 Accessed: January 17, 2017.
27. (Producer)Wilson D, S.J., Newborns die after being sent home with mothers struggling to kick drug addictions. Reuters. Available: www.reuters.com/investigates/special-report/baby-opioids/ Accessed: January 17, 2017, 2015.
28. Wright, T.E., Terplan, M., Ondersma, S.J., Boyce, C., Yonkers, K., Chang, G., Creanga, A.A., The role of screening, brief intervention, and referral to treatment in the perinatal period. American Journal of Obstetrics & Gynecology 215:5 (2016), 539–547.
29. Young, N.K., Gardner, S., Otero, C., Deniis, K., Chang, R., Early, K., Amatetti, S., Substance-exposed infants: State responses to the problem. Rockville, MD; Available: www.ncsacw.samhsa.gov/files/Substance-Exposed-Infants.pdf, 2009 Accessed: January 17, 2017.